Direct answer:Cosmetics labels are predominantly FP&C Act, FPLA and 21 CFR Parts 701, 740 The product claims to be a drug, and it cannot be judged on the basis of brand categories alone. Manufacturers, brand owners, importers, and label design teams that sell cosmetics to the United States.

_Other OrganiserManufacturers, brand owners, importers and label design teams that sell cosmetics to the United States.

Which products and enterprises do this apply to?

Cosmetics labels are predominantly FP&C Act, FPLA and 21 CFR Parts 701, 740 The product claims that it may be a drug at the same time and cannot be judged by brand categories alone.

The product categories should be checked in conjunction with product uses, constituents or technical characteristics, labelling claims, production/import activities and corporate roles; When the information is insufficient, the facts are identified.

What are the rules or concepts?

United States cosmetic labels are required to check identity, net content, responsible parties and composition information according to the nature of the product, packaging and declaration.

The official requirements described in this document are based on the relevant bills, regulations and the official FDA page. The information and process proposals set out below are part of the site’s substantive recommendations and do not replace statutory obligations.

How do you determine whether you need to do this?

  1. Identify legal categories of products, intended uses and target markets.
  2. Lists manufacturers, brands/labellers, importers and U.S. agents.
  3. Identification of specific regulatory actions against official scope of application, exemptions and exceptions; Retention issues in cases of uncertainty and further verification.

What needs to be prepared, and how do you usually handle it?

(b) Prejudice products are cosmetics, pharmaceuticals or both; Check the master display, net content, name address of the responsible party, composition statement, warning and declaration; Review internal and external packaging and distribution channels.

  • Product uses, formulations/descriptions, labelling and manufacturing information;
  • (a) Information on the facility and the subject of the enterprise, the responsible party and the records of the submission;
  • The official rules are based, the questions to be checked and the internal authority responsible.

Common error zones, exceptions and risk boundaries

FDA does not pre-authorize general cosmetic labels; Colour additives, pharmaceutical declarations and additional requirements for specific uses.

Real project cases are not publicly available and therefore no fictional client cases are added. Product boundaries or special exemptions should be judged by specific facts and official documents.

Official sources are checked with recent information.

Date of official data check: 2026-11-04. The applicability should be re-checked after updating the FDA page or legislation.

What's next?

The product, the role of the enterprise, the target market and existing records are collated and the path is checked against the official information listed here. You can also see FDA Knowledge Base、Scope of related services| Or through Contact PageSubmission of specific information.

Continue reading and preparation

Further consolidation of project information is availableCosmetics label review; The scope, processing cycles and costs are shown on the corresponding service page.